SubsidieMeestersAdvancing Transcatheter Mitral Valve Repair
The Mitral butterfly implant is a self-expanding device designed to stabilize the heart's posterior leaflet, enhancing coaptation and minimizing surgical complexity during delivery.
Projectdetails
Introduction
The Mitral butterfly implant is a posterior leaflet augmentation device which functions to prevent excessive posterior leaflet motion.
Components of the Implant
The implant comprises three main components:
- Nitinol Frame: Designed to sit comfortably within the anatomy of the heart and to provide the overall structure of the implant.
- Artificial Leaflet: In the form of a flexible mesh, this component serves to restrict the prolapsing leaflet and provide a surface for adequate coaptation.
- Method of Anchoring: This is essential for securing the implant in place.
Delivery and Deployment
The implant can be folded into a catheter to facilitate delivery and be deployed in the target region with minimal actuation.
Self-Expansion and Orientation
The shape memory capabilities of nitinol allow the implant to self-expand when released. The design of the frame ensures the correct orientation within the valve. Consequently, the procedure involves minimal actuated steps, with the main mechanical complexity arising from the anchorage.
Anchorage Mechanism
The anchorage itself is achieved with a secondary self-expanding nitinol mechanism.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.999 |
| Totale projectbegroting | € 8.748.750 |
Tijdlijn
| Startdatum | 1-2-2023 |
| Einddatum | 31-1-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- AVVIE GMBHpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Innovative, minimally invasive device to support the natural movement of the heart in heart failure patientsSyntach CS is an innovative implantable device that restores natural heart movement in patients with left ventricular heart failure, enhancing cardiac function through synchronized support. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Innovative, minimally invasive Medical Prostatic Retraction Device for the treatment of Benign Prostatic Hyperplasia (BPH) Patients in the office settings.Butterfly Medical is developing a minimally invasive device for BPH treatment that enhances urine flow without surgery, aiming for post-marketing studies in Europe and pivotal FDA trials in the US. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Minimally invasive suturing for vascular bore closure and heart defect repairNovelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Transcatheter Ventricular Repair Device for treatment of Heart Failure PatientsCardiac Success aims to develop the V-sling, a transcatheter device to enhance heart function in heart failure patients, through product optimization and pre-clinical testing. | EIC Accelerator | € 2.500.000 | 2022 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Innovative, minimally invasive device to support the natural movement of the heart in heart failure patients
Syntach CS is an innovative implantable device that restores natural heart movement in patients with left ventricular heart failure, enhancing cardiac function through synchronized support.
Innovative, minimally invasive Medical Prostatic Retraction Device for the treatment of Benign Prostatic Hyperplasia (BPH) Patients in the office settings.
Butterfly Medical is developing a minimally invasive device for BPH treatment that enhances urine flow without surgery, aiming for post-marketing studies in Europe and pivotal FDA trials in the US.
Minimally invasive suturing for vascular bore closure and heart defect repair
Novelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures.
Transcatheter Ventricular Repair Device for treatment of Heart Failure Patients
Cardiac Success aims to develop the V-sling, a transcatheter device to enhance heart function in heart failure patients, through product optimization and pre-clinical testing.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
biomimetic engineered chordae tendineae for valve repair and regenerationThis project aims to develop and validate BioChord, a bioengineered regenerative chordae tendineae for mitral valve repair, enhancing durability and promoting tissue restoration. | ERC Proof of... | € 150.000 | 2023 | Details |
Flow Controlled Prosthetic Heart ValvesStreamlineValve aims to develop a flow-controlled prosthetic heart valve that enhances durability and safety while reducing the need for anticoagulation therapy through optimized blood flow. | ERC Proof of... | € 150.000 | 2024 | Details |
MicroHeartHet project ontwikkelt een gestandaardiseerd productieproces voor de ELANA Heart Bypass, een minimaal-invasieve behandeling voor coronaire hartziekten, ter verbetering van patiëntenzorg en commercialisatie. | Mkb-innovati... | € 155.525 | 2018 | Details |
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restorationBIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness. | EIC Pathfinder | € 4.039.541 | 2022 | Details |
NanoStentDit project ontwikkelt een volledig opneembare stent voor de behandeling van kritische ischemie, ter vermindering van amputaties en zorgkosten. | Mkb-innovati... | € 350.000 | 2022 | Details |
biomimetic engineered chordae tendineae for valve repair and regeneration
This project aims to develop and validate BioChord, a bioengineered regenerative chordae tendineae for mitral valve repair, enhancing durability and promoting tissue restoration.
Flow Controlled Prosthetic Heart Valves
StreamlineValve aims to develop a flow-controlled prosthetic heart valve that enhances durability and safety while reducing the need for anticoagulation therapy through optimized blood flow.
MicroHeart
Het project ontwikkelt een gestandaardiseerd productieproces voor de ELANA Heart Bypass, een minimaal-invasieve behandeling voor coronaire hartziekten, ter verbetering van patiëntenzorg en commercialisatie.
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration
BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.
NanoStent
Dit project ontwikkelt een volledig opneembare stent voor de behandeling van kritische ischemie, ter vermindering van amputaties en zorgkosten.